TRPC5 and breast carcinoma: It is conceivable that the observed proliferative effect arises through the transfer and incorporation of functional TRPC3 channels into the membrane of recipient cells—as reported for the EV‐mediated transfer of TRPC5 from chemoresistant breast cancer cells (Ma et al., 2014).